iX Biopharma unit obtains Australia licence to bring product testing in-house

Singapore

IX Biopharma on Monday said it has obtained a licence in Australia to bring its product testing in-house, improving speed-to-market and potentially saving on testing costs.

The pharmaceutical company's wholly-owned subsidiary iX Syrinx obtained a Good Manufacturing Practice (GMP) licence from the Therapeutic Goods Administration of…

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

Sign UpVIEW ALL